Advertisement
Free access | 10.1172/JCI107623
Immunology Branch, National Cancer Institute, Bethesda, Maryland 20014
Find articles by Dickler, H. in: JCI | PubMed | Google Scholar
Immunology Branch, National Cancer Institute, Bethesda, Maryland 20014
Find articles by Adkinson, N. in: JCI | PubMed | Google Scholar
Immunology Branch, National Cancer Institute, Bethesda, Maryland 20014
Find articles by Fisher, R. in: JCI | PubMed | Google Scholar
Immunology Branch, National Cancer Institute, Bethesda, Maryland 20014
Find articles by Terry, W. in: JCI | PubMed | Google Scholar
Published March 1, 1974 - More info
Peripheral blood lymphocytes from 15 patients with variable immunodeficiency and severe panhypogammaglobulinemia were evaluated for B and T cell surface markers. B cells were enumerated by immunofluorescent detection of both surface immunoglobulin (Ig) and the ability to bind aggregated Ig complexes. T cells were identified by their ability to form nonimmune rosettes with sheep red blood cells. Four distinct patterns were observed which were designated types I-IV. Type I: six patients had normal percentages (8.5-19.0%) of Ig-bearing B lymphocytes. Type II: four patients were observed to have B lymphocytes (4.5-15.0%) which lacked fluorescence-detectable surface Ig. Type III: the peripheral blood of these four patients contained a subpopulation (11.3-20.0%) of lymphocytes which apparently lacked both B and T cell markers (“null” cells). Type IV: one patient's blood was characterized by a subpopulation (18.0-22.0%) of lymphocytes which bore both B and T cell markers. Patients of each type had some clinical features in common. It is concluded that evaluation of lymphocyte surface markers provides a means of separating patients with variable immunodeficiency and panhypogammaglobulinemia into distinct groups which appear to differ in the nature of their fundamental defect.